In partnership with NHS England, Genomics England's ambitious plans to embed genomic
medicine into routine patient care are well underway. Clare Turnbull and colleagues discuss …

Respiratory infections are the third leading cause of death worldwide. Illness is caused by
pathogen replication and disruption of airway homeostasis by excessive expansion of cell …

The kinase-activating mutation G2019S in leucine-rich repeat kinase 2 (LRRK2) is one of the
most common genetic causes of Parkinson’s disease (PD) and has spurred development …

A global team of influential researchers, clinicians, regulators, and citizen advocates suggest
how we can start to build an evidence base for healthcare that is free of commercial …

Objectives Rapid, high throughput diagnostics are a valuable tool, allowing the detection of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in populations so as to …

Genomic sequencing is rapidly transitioning into clinical practice, and implementation into
healthcare systems has been supported by substantial government investment, totaling over …

Background Patterns of health-care use and comorbidities present in patients in the period
before diagnosis of chronic obstructive pulmonary disease (COPD) are unknown. We …

The Cancer Programme of the 100,000 Genomes Project was an initiative to provide whole-genome
sequencing (WGS) for patients with cancer, evaluating opportunities for precision …

Background Repeat expansion disorders affect about 1 in 3000 individuals and are clinically
heterogeneous diseases caused by expansions of short tandem DNA repeats. Genetic …

Molecular diagnostics is a cornerstone of modern precision medicine, broadly understood
as tailoring an individual's treatment, follow‐up, and care based on molecular data. In rare …